Intrinsic Value

The intrinsic value of Novozymes A/S (NZM2) under the Base Case is EUR per share. Compared with the current market price of 58.26 EUR, the stock appears .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

NZM2 Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Intrinsic value for the past 5 years is hidden
Alert me when NZM2 is below its intrinsic value
Today Hidden ·
Alternatives to NZM2

Fundamental Analysis

What Novozymes A/S Does

Chemicals Materials

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly.

Headquarters
Denmark DK
Employees
6 184
IPO date
May 27, 1905
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue NZM2 Research

Decided on Novozymes A/S? Get an email when NZM2 reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one NZM2 stock?

The intrinsic value for Novozymes A/S (NZM2) under the Base Case is EUR.

Is NZM2 stock undervalued or overvalued?

Compared with the current market price of 58.26 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top